Modulation of the chemotactic peptide- and immunoglobulin G-triggered respiratory burst in human neutrophils by exogenous and endogenous adenosine

European Journal of Pharmacology

Volumn 354, Issue 2-3, 1998, Pages 215-225

  Zalavary, Stefan ^a   Bengtsson, Torbjörn ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Adenosine; cAMP; Chemiluminescence; Neutrophil; Respiratory burst

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE DERIVATIVE; CHEMOTACTIC PEPTIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEOXYADENOSINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; IMMUNOGLOBULIN G; OXYGEN;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST;

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE; CHEMILUMINESCENT MEASUREMENTS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME REPRESSION; HUMANS; IMMUNOGLOBULIN G; LUMINOL; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RECEPTORS, PURINERGIC P1; RESPIRATORY BURST; SIGNAL TRANSDUCTION; YEASTS;

EID: 0031687642     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00461-0     Document Type: Article

References (57)

1. 2+ influx. J. Biol. Chem. 270, 23816-23822.
2. Barankiewicz, J., Jimenez, R., Uyesaka, J., Colmerauer, E., Firestein, G.S., 1995. Endogenous adenosine formation can regulate human neutrophil function. In: Sahota, A., Taylor, M. (Eds.), Purine and pyrimidine metabolism in man VIII. Plenum, New York, NY, pp. 417-421.
3. Bengis-Garber, C., Gruener, N., 1996. Protein kinase A downregulates the phosphorylation of p47 phox in human neutrophils: a possible pathway for inhibition of the respiratory burst. Cell. Signal. 8, 291-296.
4. Bengtsson, T., Zalavary, S., Stendahl, O., Grenegård, M., 1996. Release of oxygen metabolites from chemoattractant-stimulated neutrophils is inhibited by resting platelets: role of extracellular adenosine and actin polymerization. Blood 87, 4411-4423.
5. Burkey, T.H., Webster, R.O., 1993. Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by human neutrophils at an early step in signal transduction. Biochim. Biophys. Acta 1175, 312-318.
6. Böyum, A., 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 97, 77-89.
7. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., Hidaka, H., 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265, 5267-5272.
8. Coffey, R.G., 1992. Effects of cyclic nucleotides on granulocytes. Immunol. Ser. 57, 301-338.
9. Cronstein, B.N., 1994. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76, 5-13.
10. Cronstein, B.N., 1995. A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites. J. Invest. Med. 43, 50-57.
11. 2 receptor occupancy inhibits the sustained, but not the early, events of stimulus transduction in human neutrophils by a mechanism independent of actin-filament formation. Biochem. J. 281, 631-635.
12. 2 receptor on human neutrophils. J. Immunol. 135, 1366-1371.
13. Cronstein, B.N., Levin, R.I., Belanoff, J., Weissmann, G., Hirschhorn, R., 1986. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J. Clin. Invest. 78, 760-770.
14. 2-) release by activated human neutrophils. Clin. Immunol. Immunopathol. 42, 76-85.
15. Cronstein, B.N., Kramer, S.B., Rosenstein, E.D., Korchak, H.M., Weissman, G., Hirschhorn, R., 1988. Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization. Biochem. J. 252, 709-715.
16. Cronstein, B.N., Rose, F.R., Pugliese, C., 1989. Adenosine, a cytoprotective autocoid: effects of adenosine on neutrophil plasma membrane viscosity and chemoattractant receptor display. Biochim. Biophys. Acta 987, 176-180.
17. 2 generation, respectively. J. Clin. Invest. 85, 1150-1157.
18. α s-linked receptors uncouples chemoattractant receptors from their stimulus-transduction mechanisms in the neutrophil. Blood 80, 1052-1057.
19. 2 receptors. J. Immunol. 148, 2201-2206.
20. Cronstein, B.N., Naime, D., Ostad, E., 1993. The anti-inflammatory mechanism of methotrexate: Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92, 2675-2682.
21. Curnutte, J.T., Erickson, R.W., Ding, J., Badwey, J.A., 1994. Reciprocal interactions between protein kinase C and components of the NADPH oxidase complex may regulate superoxide production by neutrophils stimulated with a phorbol ester. J. Biol. Chem. 269, 10813-10819.
22. Dahlgren, C., Follin, P., Johansson, A., Lock, R., Lundqvist, H., Walan, A., 1991. Chemiluminescence as a means of following the function of phagocytic cells. Trends Photochem. Photobiol. 2, 427-443.
23. Deo, Y.M., Graziano, R.F., Repp, R., van de Winkel, J.G.J., 1997. Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies. Immunol. Today 18, 127-135.
24. Ernst, E., Hammerschmidt, D.E., Bagge, U., Matrai, A., Dormandy, J.A., 1987. Leukocytes and the risk of ischemic diseases. JAMA 257, 2318-2324.
25. Firestein, G.S., 1996. Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation. Drug Dev. Res. 39, 371-376.
26. Fox, I.H., Kelley, W.N., 1978. The role of adenosine and 2′-deoxyadenosine in mammalian cells. Annu. Rev. Biochem. 47, 655-686.
27. Fredholm, B.B., 1997. Purines and neutrophil leukocytes. Gen. Pharmacol. 28, 345-350.
28. 2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leukocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 354, 262-267.
29. Gadangi, P., Longaker, M., Naime, D., Levin, R.I., Recht, P.A., Montesinos, M.C., Buckley, M.T., Carlin, G., Cronstein, B.N., 1996. The anti-inflammatory effects of sulfasalazine is related to adenosine release at inflamed sites. J. Immunol. 156, 1937-1941.
30. Gilbertsen, R.B., 1987. Adenosine and adenosine receptors in immune function. Minireview and meeting report. Agents and Actions 22, 91-97.
31. Iannone, M.A., Zimmerman, T.P., Reynolds-Vaughn, R., Wolberg, G., 1987. Effects of adenosine on human neutrophil function and cyclic AMP content. In: Gerlach, E., Becker, B.F. (Eds.), Topics and perspectives in adenosine research. Springer, Berlin, pp. 286-298.
32. Kubersky, S.M., Hirschhorn, R., Broekman, M.J., Cronstein, B.N., 1989. Occupancy of adenosine receptors of human neutrophils inhibits respiratory burst stimulated by ingestion of complement-coated particles and occupancy of chemoattractant but not Fc receptors. Inflammation 13, 591-599.
33. Maggirwar, S.B., Dhanraj, D.N., Somani, S.M., Ramkumar, V., 1994. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem. Biophys. Res. Commun. 201, 508-515.
34. Mitsuyama, T., Takeshige, K., Furuno, T., Tanaka, T., Hidaka, K., Abe, M., Hara, N., 1995. An inhibitor of cyclic AMP-dependent protein kinase enhances the superoxide production of human neutrophils stimulated by N-formyl-methionyl-leucyl-phenylalanine. Mol. Cell. Biochem. 145, 19-24.
35. Mueller, H., Sklar, L.A., 1989. Coupling of antagonistic signalling pathways in modulation of neutrophil function. J. Cell. Biochem. 40, 287-294.
36. Mueller, H., Montoya, B., Sklar, L.A., 1992. Reversal of inhibitory pathways in neutrophils by protein kinase antagonists: a rational approach to the restoration of depressed cell function?. J. Leukocyte Biol. 52, 400-406.
37. Newby, A.C., 1981. The interaction of inhibitors with adenosine metabolising enzymes in intact isolated cells. Biochem. Pharmacol. 30, 2611-2615.
38. Nielson, C.P., Vestal, R.E., 1989. Effects of adenosine on polymorphonuclear leukocyte function, cyclic 3′:5′-adenosine monophosphate, and intracellular calcium. Br. J. Pharmacol. 97, 882-888.
39. Paul, S., Feoktistov, I., Hollister, A.S., Robertson, D., Biaggioni, I., 1990. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Mol. Pharmacol. 37, 870-875.
40. Quilliam, L.A., Mueller, H., Bohl, B.P., Prossnitz, V., Sklar, L.A., Der, C.J., Bokoch, G.M., 1991. Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J. Immunol. 147, 1628-1635.
41. 2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J. Biol. Chem. 271, 17114-17118.
42. Rider, L.G., Niedel, J.E., 1987. Diacylglycerol accumulation and superoxide anion production in stimulated human neutrophils. J. Biol. Chem. 262, 5603-5608.
43. Roos, D., 1994. The genetic basis of chronic granulomatous disease. Immunol. Rev. 138, 121-157.
44. Rosen, G.M., Pou, S., Ramos, C.L., Cohen, M.S., Britigan, B.E., 1995. Free radicals and phagocytic cells. FASEB J. 9, 200-209.
45. Rosengren, S., Bong, G.W., Firestein, G.S., 1995. Anti-inflammatory effects of an adenosine kinase inhibitor: Decreased neutrophil accumulation and vascular leakage. J. Immunol. 154, 5444-5451.
46. 2 receptors are inhibitory. J. Immunol. 145, 2235-2240.
47. Spisani, S., Pareschi, M.C., Buzzi, M., Colamussi, M.L., Biondi, C., Traniello, S., Zecchini, G.P., Paradisi, M.P., Torrini, I., Ferretti, M.E., 1996. Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides. Cell. Signal. 8, 269-277.
48. Stiles, G.L., 1992. Adenosine receptors. J. Biol. Chem. 267, 6451-6454.
49. Thorn, J.A., Jarvis, S.M., 1996. Adenosine transporters. Gen. Pharmacol. 27, 613-620.
50. Tyagi, S.R., Olson, S.C., Burnham, D.N., Lambeth, J.D., 1991. Cyclic AMP-elevating agents block chemoattractant activation of diradylglycerol generation by inhibiting phospholipase D activation. J. Biol. Chem. 266, 3498-3504.
51. Van Waeg, G., Van den Berghe, G., 1991. Purine catabolism in polymorphonuclear neutrophils: phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase. J. Clin. Invest. 87, 305-312.
52. Walker, B.A.M., Hagenlocker, B.E., Douglas, V.K., Ward, P.A., 1990. Effects of adenosine on inositol 1,4,5-trisphosphate formation and intracellular calcium changes in formyl-Met-Leu-Phe-stimulated human neutrophils. J. Leukocyte Biol. 48, 281-283.
53. Weiss, S.J., 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365-376.
54. Ydrenius, L., Molony, L., Ng-Sikorsky, J., Andersson, T., 1997. Dual action of cAMP-dependent protein kinase on granulocyte movement. Biochem. Biophys. Res. Commun. 235, 445-450.
55. Zalavary, S., Bengtsson, T., 1998. Adenosine inhibits actin dynamics in human neutrophils: evidence for the involvement of cAMP. Eur. J. Cell Biol. 75, 128-139.
56. Zalavary, S., Stendahl, O., Bengtsson, T., 1994. The role of cyclic AMP, calcium and filamentous actin in adenosine modulation of Fc receptor-mediated phagocytosis in human neutrophils. Biochim. Biophys. Acta 1222, 249-256.
57. Zalavary, S., Grenegård, M., Stendahl, O., Bengtsson, T., 1996. Platelets enhance Fcγ receptor-mediated phagocytosis and respiratory burst in neutrophils: the role of purinergic modulation and actin polymerization. J. Leukocyte Biol. 60, 58-68.